| Todd W Aud, CRNA | |
|
815 E Parrish Ave, Suite 460, Owensboro, KY 42303-3222 | |
| (270) 684-5005 | |
| (270) 926-4432 |
| Full Name | Todd W Aud |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 23 Years |
| Location | 815 E Parrish Ave, Owensboro, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639250616 | NPI | - | NPPES |
| 200379000 | Medicaid | IN | |
| 74004425 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 3605A (Kentucky) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | 28130190A (Indiana) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Owensboro Health Regional Hospital | Owensboro, KY | Hospital |
| Hardin Memorial Hospital | Elizabethtown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Professional Anesthesia Services Of Kentucky Pllc | 0244590305 | 148 |
| Northstar Anesthesia Of Kentucky, Pllc | 8628248069 | 42 |
News Archive
China Nuokang Bio-Pharmaceutical Inc., a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that two of its product pipeline candidates recently advanced through the next respective stages of the State Food and Drug Administration review process.
The researchers found that Rad9, previously considered a "watchman" that checks for DNA damage, is actually a "repairman" that fixes dangerous breaks in the DNA double helix. They found Rad9 is especially active in telomeres, the protective ends of chromosomes.
Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.
Americans are increasingly scrutinizing their drug choices to find ones that work but don't break the bank. The Associated Press reports: "Last year pharmaceutical companies spent more than $4 billion urging patients like you to 'ask your doctor' about their drugs. But if you want a prescription that won't empty your wallet, while still keeping you well, you might start asking your doctor about drugs you don't see on TV.
› Verified 6 days ago
| Entity Name | Commonwealth Anesthesia, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437196300 PECOS PAC ID: 5092627521 Enrollment ID: O20031104000115 |
News Archive
China Nuokang Bio-Pharmaceutical Inc., a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that two of its product pipeline candidates recently advanced through the next respective stages of the State Food and Drug Administration review process.
The researchers found that Rad9, previously considered a "watchman" that checks for DNA damage, is actually a "repairman" that fixes dangerous breaks in the DNA double helix. They found Rad9 is especially active in telomeres, the protective ends of chromosomes.
Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.
Americans are increasingly scrutinizing their drug choices to find ones that work but don't break the bank. The Associated Press reports: "Last year pharmaceutical companies spent more than $4 billion urging patients like you to 'ask your doctor' about their drugs. But if you want a prescription that won't empty your wallet, while still keeping you well, you might start asking your doctor about drugs you don't see on TV.
› Verified 6 days ago
| Entity Name | Northstar Anesthesia Of Kentucky, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386938900 PECOS PAC ID: 8628248069 Enrollment ID: O20110823000443 |
News Archive
China Nuokang Bio-Pharmaceutical Inc., a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that two of its product pipeline candidates recently advanced through the next respective stages of the State Food and Drug Administration review process.
The researchers found that Rad9, previously considered a "watchman" that checks for DNA damage, is actually a "repairman" that fixes dangerous breaks in the DNA double helix. They found Rad9 is especially active in telomeres, the protective ends of chromosomes.
Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.
Americans are increasingly scrutinizing their drug choices to find ones that work but don't break the bank. The Associated Press reports: "Last year pharmaceutical companies spent more than $4 billion urging patients like you to 'ask your doctor' about their drugs. But if you want a prescription that won't empty your wallet, while still keeping you well, you might start asking your doctor about drugs you don't see on TV.
› Verified 6 days ago
| Entity Name | Professional Anesthesia Services Of Kentucky Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992212807 PECOS PAC ID: 0244590305 Enrollment ID: O20180209000936 |
News Archive
China Nuokang Bio-Pharmaceutical Inc., a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that two of its product pipeline candidates recently advanced through the next respective stages of the State Food and Drug Administration review process.
The researchers found that Rad9, previously considered a "watchman" that checks for DNA damage, is actually a "repairman" that fixes dangerous breaks in the DNA double helix. They found Rad9 is especially active in telomeres, the protective ends of chromosomes.
Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.
Americans are increasingly scrutinizing their drug choices to find ones that work but don't break the bank. The Associated Press reports: "Last year pharmaceutical companies spent more than $4 billion urging patients like you to 'ask your doctor' about their drugs. But if you want a prescription that won't empty your wallet, while still keeping you well, you might start asking your doctor about drugs you don't see on TV.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Todd W Aud, CRNA 6170 Sonoma Ct, Owensboro, KY 42303-9229 Ph: (270) 684-5005 | Todd W Aud, CRNA 815 E Parrish Ave, Suite 460, Owensboro, KY 42303-3222 Ph: (270) 684-5005 |
News Archive
China Nuokang Bio-Pharmaceutical Inc., a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that two of its product pipeline candidates recently advanced through the next respective stages of the State Food and Drug Administration review process.
The researchers found that Rad9, previously considered a "watchman" that checks for DNA damage, is actually a "repairman" that fixes dangerous breaks in the DNA double helix. They found Rad9 is especially active in telomeres, the protective ends of chromosomes.
Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.
Americans are increasingly scrutinizing their drug choices to find ones that work but don't break the bank. The Associated Press reports: "Last year pharmaceutical companies spent more than $4 billion urging patients like you to 'ask your doctor' about their drugs. But if you want a prescription that won't empty your wallet, while still keeping you well, you might start asking your doctor about drugs you don't see on TV.
› Verified 6 days ago
Carla Ann Atherton, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 815 E Parrish Ave, Suite 460, Owensboro, KY 42303 Phone: 270-684-5005 | |
Mr. John A Keller, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 815 E Parrish Ave, Suite 460, Owensboro, KY 42303 Phone: 270-684-5005 Fax: 270-926-4432 | |
Daniel L Huther, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2900 Veach Rd, Ste 3, Owensboro, KY 42303 Phone: 270-684-5005 | |
Mr. Jeremy Dean Morris, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 815 E Parrish Ave, Suite 460, Owensboro, KY 42303 Phone: 270-684-5005 Fax: 270-926-4432 | |
Lisa A Scheller, APRN, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1201 Pleasant Valley Rd, Owensboro, KY 42303 Phone: 270-417-2000 | |
Jonathan Embry, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1201 Pleasant Valley Rd, Owensboro, KY 42303 Phone: 270-417-2000 | |
Mrs. Haley T Morris, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 815 E Parrish Ave, Suite 460, Owensboro, KY 42303 Phone: 270-684-5005 Fax: 270-926-4432 |